Can't get enough about new personalized med companies? A blogger reviews 23andMe, Helix Health, and, of course, Navigenics.
A blogger gives pointers on DNA gel extraction.
An article from the New York Times delves into rising concerns about prejudice in "the DNA era."
This week's Science reports on ER stress, mTOR, a biomarker for neural progenitor cells, and more.
A blogger lists 20 Facebook applications for scientists.
A blogger wonders if flexible spending accounts will cover personal genetic tests.
A blogger talks about his experience as an undergraduate scientist.
The Wellcome Trust sponsors a large-scale study on teenagers' attitudes toward genetics.
NOVA will broadcast a program about the Dover intelligent design court case.
This week's Nature has Drosophila, high resolution protein structure modeling, the NIH, and more.
VentureBeat's David Hamilton takes a closer look at Navigenics' product.
The dandruff-causing fungus's genome is sequenced.
A new idea for paper authorship is to be like a movie's credit roll.
Derek Lowe discusses the link between pharma and the movie business.
A blogger lists why not to be a scientist.
PubMed adds drug information to its articles.
Jonathan Eisen supports open access.
A series of papers in PLoS Biology discuss how sex ratio is influenced by RNAi.
Direct-to-consumer genetic tests will be launched next year.
MIT's Technology Review interviews the Whitehead Institute's Robert Weinberg.
Population genomics research looks at a relative of D. melanogaster, Drosophila simulans.
Lung adenocarcinomas genomes contain copy number changes.
Blogger David Ng has a song about scientific jargon.
GMO plants will use RNAi to kill pests.
Baylor pairs next-gen sequencing with microarrays with for resequencing.
The Guardian reports that visa costs could prevent scientists and others from coming to the UK.
The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.
Nature News says some preprint repositories may close down due to a lack of funds to cover costs.
In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.